2024
Return-to-Play After Plasmodium falciparum Malaria in a Professional American Football Player
Mun J, Ryan E, Whalen J, Martin S. Return-to-Play After Plasmodium falciparum Malaria in a Professional American Football Player. JBJS Case Connector 2024, 14: e24.00457. PMCID: PMC11581430, DOI: 10.2106/jbjs.cc.24.00457.Peer-Reviewed Original ResearchPlasmodium falciparum malariaPersistent splenomegalyHigh-grade feverProfessional American football playersAmerican football playersFalciparum malariaFootball playersPatient's symptomsCollision sport athletesMalariaEmergency departmentReturn-to-playBlood smearsHospital admissionRisk of deconditioningSplenomegalyNoncontact activityPatientsSport athletesSymptomsWeeksPlasmodiumOn-fieldFeverSmears
2006
Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.
HILL D, BAIRD J, PARISE M, LEWIS L, RYAN E, MAGILL A. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. American Journal Of Tropical Medicine And Hygiene 2006, 75: 402-15. PMID: 16968913, DOI: 10.4269/ajtmh.2006.75.402.Peer-Reviewed Original ResearchConceptsP. ovale malariaPrimary prophylaxisAdult doseRelapses of Plasmodium vivaxAnti-relapse therapyRecommended adult doseMalaria speciesP. vivaxPlasmodium vivaxBlood schizonticideDeficiency of G6PDLiver stagesMalarious regionsRadical cureEstablished infectionPrevent relapseClinical trialsMalariaProphylaxisPrimaquineDosePrimaquine phosphateGlucose-6-phosphate dehydrogenaseDaysGlucose-6-phosphate